Pathogenetic mechanisms in chronic myeloproliferative disorders

Polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The stem cell origination of the clonal process in chronic myeloproliferative disorders (CMPDs) is well established. In chronic myelogenous leukemia (CML), the primary genetic process has been characterized. However, current information regarding the mechanisms of phenotypic diversity among the CMPD and the downstream effects of the cbromosomal translocation in CML remains inconclusive. In this report, the current understanding regarding erythrocytosis in polycythemia vera (PV), thrombocytosis in essential thrombocythemia (ET), bone marrow fibrosis (BMF) in agnogenic myeloid metaplasia (AMM), and the connection between the genetic alteration and cellular transformation in CML will be discussed.

Original languageEnglish (US)
Pages (from-to)3-8
Number of pages6
JournalSeminars in Hematology
Volume36
Issue numberSUPPL. 2
StatePublished - 1999

Fingerprint

Essential Thrombocythemia
Myeloproliferative Disorders
Polycythemia Vera
Primary Myelofibrosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Genetic Phenomena
Thrombocytosis
Polycythemia
Stem Cells

ASJC Scopus subject areas

  • Hematology

Cite this

@article{d4718a05398b40bba18dac205e7ff228,
title = "Pathogenetic mechanisms in chronic myeloproliferative disorders: Polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia",
abstract = "The stem cell origination of the clonal process in chronic myeloproliferative disorders (CMPDs) is well established. In chronic myelogenous leukemia (CML), the primary genetic process has been characterized. However, current information regarding the mechanisms of phenotypic diversity among the CMPD and the downstream effects of the cbromosomal translocation in CML remains inconclusive. In this report, the current understanding regarding erythrocytosis in polycythemia vera (PV), thrombocytosis in essential thrombocythemia (ET), bone marrow fibrosis (BMF) in agnogenic myeloid metaplasia (AMM), and the connection between the genetic alteration and cellular transformation in CML will be discussed.",
author = "Ayalew Tefferi",
year = "1999",
language = "English (US)",
volume = "36",
pages = "3--8",
journal = "Seminars in Hematology",
issn = "0037-1963",
publisher = "W.B. Saunders Ltd",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Pathogenetic mechanisms in chronic myeloproliferative disorders

T2 - Polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia

AU - Tefferi, Ayalew

PY - 1999

Y1 - 1999

N2 - The stem cell origination of the clonal process in chronic myeloproliferative disorders (CMPDs) is well established. In chronic myelogenous leukemia (CML), the primary genetic process has been characterized. However, current information regarding the mechanisms of phenotypic diversity among the CMPD and the downstream effects of the cbromosomal translocation in CML remains inconclusive. In this report, the current understanding regarding erythrocytosis in polycythemia vera (PV), thrombocytosis in essential thrombocythemia (ET), bone marrow fibrosis (BMF) in agnogenic myeloid metaplasia (AMM), and the connection between the genetic alteration and cellular transformation in CML will be discussed.

AB - The stem cell origination of the clonal process in chronic myeloproliferative disorders (CMPDs) is well established. In chronic myelogenous leukemia (CML), the primary genetic process has been characterized. However, current information regarding the mechanisms of phenotypic diversity among the CMPD and the downstream effects of the cbromosomal translocation in CML remains inconclusive. In this report, the current understanding regarding erythrocytosis in polycythemia vera (PV), thrombocytosis in essential thrombocythemia (ET), bone marrow fibrosis (BMF) in agnogenic myeloid metaplasia (AMM), and the connection between the genetic alteration and cellular transformation in CML will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=0032947629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032947629&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 3

EP - 8

JO - Seminars in Hematology

JF - Seminars in Hematology

SN - 0037-1963

IS - SUPPL. 2

ER -